Current Categories of Treatment
Current osteoporosis treatments fall into 2 categories:
anabolic and antiresorptive agents1,2
1. Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the diagnosis and
treatment of postmenopausal osteoporosis—2016. Endocr Pract. 2016; (Suppl 4):1-42.
2. Baron R, Hesse E. Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives. J Clin Endocrinol Metab. 2012;97(2):311-325.
3. Girotra M, Rubin MR, Bilezikian JP. Anabolic agents for osteoporosis. What is their likely place in therapy? Treat Endocrinol. 2006;5(6):347-358.
4. Khan AW, Khan A. Anabolic agents: a new chapter in the management of osteoporosis. J Obstet Gynaecol Can. 2006;28(2):136-141.
5. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423(6937):337-342.
6. Seeman E, Delmas PD. Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250-2261.
7. Farr JN, Khosla S. Skeletal changes through the lifespan—from growth to senescence. Nat Rev Endocrinol. 2015;11(9):513-521.
8. National Institutes of Health, National Institute on Aging. Menopause. 2013. https://www.nia.nih.gov/health/publication/menopause. Accessed November 9, 2016.